Back to Diseases & Conditions

Plexiform neurofibroma

Plexiform neurofibroma also is called PN or PNF. It is a type of noncancerous tumor called neurofibroma that forms in or around a nerve. Neurofibromas grow on the protective covering around the nerve, called the nerve sheath. When a neurofibroma grows on several nerve bundles, it’s called a plexiform neurofibroma.

The tumor grows along the nerve and can spread into nearby tissues such as skin, fat, bone and muscle. Plexiform neurofibroma is most often seen in people with a condition caused by a change in genes that affects how nerve cells grow and develop, called neurofibromatosis type 1 (NF1). Up to half of the people with NF1 develop plexiform neurofibromas.

Plexiform neurofibromas are different from other nerve tumors because they spread out in a networklike pattern. These tumors are known for their distinctive “bag of worms” texture, which means they feel like a bundle of tangled cords or threads. This is a classic sign of a plexiform neurofibroma.

Plexiform neurofibromas are most common in childhood and adolescence. Some people may notice swelling or a soft lump under the skin. These tumors often grow in the head, neck, trunk, arms or legs, but they can appear anywhere in the body.

Treatment depends on the size, location and symptoms of the plexiform neurofibroma. Most plexiform neurofibromas grow slowly and are not life-threatening. But some can cause serious symptoms depending on the size or location or if they become cancerous.

Plexiform neurofibromas can cause different symptoms based on where they grow, how big they are, and how they press on nearby nerves and tissues. Some people have no symptoms at first. Others may notice changes in how their bodies look, feel or move.

Common signs and symptoms of plexiform neurofibroma include:

Most plexiform neurofibromas occur in people with a condition called neurofibromatosis type 1 (NF1). NF1 is caused by a change in the NF1 gene, which is located on chromosome 17. This gene typically helps control how cells grow. When it isn’t working properly, cells that support nerves may grow too much and form tumors like plexiform neurofibromas.

Plexiform neurofibromas are linked to a genetic condition called neurofibromatosis type 1 (NF1). Anyone with NF1 has a risk of developing these tumors. The number, size and location of tumors can vary from person to person.

Having NF1 is the main risk factor for plexiform neurofibroma. Up to 50% of people with NF1 will develop one or more plexiform neurofibromas during their lives.

There is no known way to prevent plexiform neurofibromas. The tumors develop because of a genetic change that is present from birth and cannot be reversed.

Plexiform neurofibromas are usually diagnosed based on a combination of medical history, physical exam and imaging tests. Most people who develop these tumors have a condition called neurofibromatosis type 1 (NF1). NF1 often is diagnosed in early childhood.

Healthcare professionals may begin by examining the body for visible signs of tumors or skin changes. When a plexiform neurofibroma is close to the surface, it may feel soft and irregular under the skin. Some tumors have a “bag of worms” texture, which means they feel like a bundle of tangled cords or threads. This is a classic sign of a plexiform neurofibroma.

Imaging for plexiform neurofibroma

Because many plexiform neurofibromas grow deep inside the body, imaging is important for understanding the size, location and impact of the tumor. Tests such as MRI or CT scans can help find tumors — even very small ones — and show whether nearby tissues are affected.

Positron emission tomography (PET) scans are not used to diagnose plexiform neurofibromas, but they can be helpful if a healthcare professional is concerned that a tumor might be becoming cancerous. PET imaging can show how active the tumor cells are, which helps distinguish a noncancerous plexiform neurofibroma from a cancerous tumor, called malignant peripheral nerve sheath tumor (MPNST). However, it can still be difficult to tell a plexiform neurofibroma from an MPNST on a PET scan. At times, surgery or biopsy is needed.

Genetic testing for plexiform neurofibroma

If a child has signs of NF1 but no family history, your healthcare professional may order a genetic test to check for changes in the NF1 gene. A diagnosis of NF1 increases the likelihood of developing plexiform neurofibromas. Genetic testing can help confirm NF1, which is diagnosed when a person has at least two of seven clinical features — one of which is a plexiform neurofibroma.

Treatment for plexiform neurofibromas depends on the size, location and symptoms of the tumor. Some tumors don’t need treatment right away. Others may require surgery or medicine to manage pain, improve function or reduce tumor size.

Accommodations for living with plexiform neurofibroma

People living with plexiform neurofibromas (PNFs) may need certain accommodations depending on tumor size, location and symptoms such as pain, fatigue or physical limitations.

Depending on your symptoms and how they impact your daily life, accommodations may include:

Prognosis

There is no cure for plexiform neurofibromas, but many people live well with them for years. Some tumors stay the same size and don’t cause symptoms, while others may grow and lead to pain, changes in appearance, or pressure on nearby nerves or tissues.

Regular checkups and imaging tests are important to watch for any changes in plexiform neurofibromas. In some cases, a plexiform neurofibroma can turn into an aggressive type of cancer called malignant peripheral nerve sheath tumor (MPNST).

Most plexiform neurofibromas do not become cancerous. With routine monitoring, and treatment when symptoms appear, many people are able to manage the tumors and maintain a good quality of life.

Potential future treatments

Researchers continue to study MEK inhibitors beyond selumetinib as treatments for plexiform neurofibromas. These medicines work by blocking signals that tell tumors to grow. This may help shrink the tumors or slow their growth.

Researchers are now studying whether other MEK inhibitors — such as trametinib (Mekinist) and binimetinib (Mektovi) — can provide similar or better tumor reduction with fewer or more manageable side effects compared with selumetinib. Cabozantinib (CABOMETYX) — a multityrosine kinase inhibitor — is under investigation.

A plexiform neurofibroma diagnosis can be overwhelming and confusing. It can make you feel like you have little control over your health. But you can take steps to cope with the shock and grief that may come after your diagnosis. Consider trying to:

See your usual healthcare professional if you have any signs or symptoms that worry you. If you’re diagnosed with a plexiform neurofibroma you may be referred to specialists, such as:

Plexiform neurofibroma tumor treatment can be complex. Few hospitals have the expertise to care for many people with these kinds of tumors. If you don’t feel comfortable with the care at your local facility, consider seeking a second opinion at a more experienced cancer center. Ask your healthcare professional for a referral.

Here’s some information to help you get ready for your appointment.

What you can do

Questions to ask at your first appointment include:

Questions to ask an oncologist or a neurologist include:

Note the three questions that are most important to you so you can be sure to get those answered if the time is limited. In addition to the questions that you’ve prepared to ask, don’t hesitate to ask other questions that occur to you.

What to expect from your doctor

Be prepared to answer questions about your symptoms and your health history. Questions may include:

© 1998-2024 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.

We Make Health Possible

As East Central Indiana’s population grows, we’re putting health care where people need it most. Besides Hancock Regional Hospital, ranked as one of the nation’s safest by the Lown Hospital Index, our network includes more than 30 autres emplacements à proximité de votre domicile ou de votre travail.

Learn More about Hancock